A detailed history of Principal Financial Group Inc transactions in Incyte Corp stock. As of the latest transaction made, Principal Financial Group Inc holds 253,352 shares of INCY stock, worth $16.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
253,352
Previous 253,638 0.11%
Holding current value
$16.7 Million
Previous $15.9 Million 9.37%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$56.55 - $66.59 $16,173 - $19,044
-286 Reduced 0.11%
253,352 $14.4 Million
Q4 2023

Feb 07, 2024

SELL
$52.16 - $64.19 $347,124 - $427,184
-6,655 Reduced 2.56%
253,638 $15.9 Million
Q3 2023

Nov 02, 2023

SELL
$57.77 - $65.93 $30,329 - $34,613
-525 Reduced 0.2%
260,293 $15 Million
Q2 2023

Aug 07, 2023

SELL
$60.95 - $75.51 $473,642 - $586,788
-7,771 Reduced 2.89%
260,818 $16.2 Million
Q1 2023

May 09, 2023

BUY
$70.23 - $86.01 $80,975 - $99,169
1,153 Added 0.43%
268,589 $19.4 Million
Q4 2022

Feb 09, 2023

SELL
$67.18 - $84.11 $203,622 - $254,937
-3,031 Reduced 1.12%
267,436 $21.5 Million
Q3 2022

Nov 09, 2022

BUY
$66.18 - $82.86 $1.89 Million - $2.37 Million
28,585 Added 11.82%
270,467 $18 Million
Q2 2022

Aug 10, 2022

BUY
$66.18 - $83.18 $327,855 - $412,073
4,954 Added 2.09%
241,882 $18.4 Million
Q1 2022

May 09, 2022

BUY
$66.02 - $79.71 $185,120 - $223,506
2,804 Added 1.2%
236,928 $18.8 Million
Q4 2021

Feb 09, 2022

SELL
$63.34 - $74.11 $263,367 - $308,149
-4,158 Reduced 1.74%
234,124 $17.2 Million
Q3 2021

Nov 09, 2021

BUY
$68.67 - $84.02 $163,159 - $199,631
2,376 Added 1.01%
238,282 $16.4 Million
Q2 2021

Aug 10, 2021

BUY
$79.87 - $87.53 $118,287 - $129,631
1,481 Added 0.63%
235,906 $0
Q1 2021

May 10, 2021

SELL
$76.02 - $100.5 $1.53 Million - $2.02 Million
-20,094 Reduced 7.89%
234,425 $19.1 Million
Q4 2020

Feb 08, 2021

SELL
$80.74 - $97.7 $1.64 Million - $1.98 Million
-20,265 Reduced 7.37%
254,519 $22.1 Million
Q3 2020

Nov 06, 2020

SELL
$85.07 - $109.69 $846,871 - $1.09 Million
-9,955 Reduced 3.5%
274,784 $0
Q2 2020

Aug 05, 2020

BUY
$74.18 - $108.93 $1.67 Million - $2.45 Million
22,457 Added 8.56%
284,739 $29.6 Million
Q1 2020

May 12, 2020

BUY
$63.18 - $85.97 $22,681 - $30,863
359 Added 0.14%
262,282 $19.2 Million
Q4 2019

Feb 05, 2020

SELL
$73.04 - $95.72 $562,919 - $737,714
-7,707 Reduced 2.86%
261,923 $22.9 Million
Q3 2019

Nov 13, 2019

SELL
$72.82 - $86.52 $255,234 - $303,252
-3,505 Reduced 1.28%
269,630 $20 Million
Q2 2019

Aug 12, 2019

SELL
$73.52 - $88.7 $1.94 Million - $2.34 Million
-26,428 Reduced 8.82%
273,135 $23.2 Million
Q1 2019

May 10, 2019

BUY
$63.56 - $88.17 $318,753 - $442,172
5,015 Added 1.7%
299,563 $25.8 Million
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $35,217 - $42,103
602 Added 0.2%
294,548 $18.7 Million
Q3 2018

Nov 14, 2018

BUY
$61.75 - $74.23 $411,316 - $494,446
6,661 Added 2.32%
293,946 $20.3 Million
Q2 2018

Aug 13, 2018

BUY
$60.85 - $83.98 $337,534 - $465,837
5,547 Added 1.97%
287,285 $0
Q1 2018

May 14, 2018

BUY
$83.06 - $100.98 $38,789 - $47,157
467 Added 0.17%
281,738 $23.5 Million
Q4 2017

Feb 13, 2018

BUY
$93.56 - $116.6 $1.81 Million - $2.25 Million
19,331 Added 7.38%
281,271 $26.6 Million
Q3 2017

Nov 02, 2017

BUY
$109.15 - $138.27 $28.6 Million - $36.2 Million
261,940
261,940 $30.6 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.